PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Phenotype | C0011303|demyelinating disease |
| Sentences | 4 |
| PubMedID- 22284064 | Central nervous system (cns) inflammatory demyelinating diseases are a group of disorders that include multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica. |
| PubMedID- 25339213 | San francisco; virginia commonwealth medical school (s.g.); lourie center for pediatric ms (l.k., a.b.), stony brook children's hospital, ny; partners ms center (t.c.), massachusetts general hospital for children, harvard medical school; uab center for pediatric onset demyelinating disease (j.n.), children's hospital of alabama; pediatric multiple sclerosis center (b.w.-g.), jacobs neurological institute, suny buffalo, ny; pediatric multiple sclerosis and related diseases program (m.g.), boston children's hospital, ma; mayo clinic's pediatric ms center (m.p., m.r.), rochester, mn; blue bird circle multiple sclerosis center (t.l.), texas children's hospital, houston; pediatric ms center at loma linda university children's hospital (g.a.), ca; multiple sclerosis center (e.m.m.), johns hopkins university, baltimore, md; department of pediatrics (j.w.r., t.s., t.c.c.), university of utah, salt lake city; oklahoma medical research foundation (j.j.), oklahoma city; and department of pediatrics (e.w.), ucsf benioff children's hospital. |
| PubMedID- 23204981 | In murine t-cell-mediated demyelinating disease model of multiple sclerosis, venlafaxine significantly ameliorated clinical symptoms of the disease in association with a reduction of il-12, tnf-α and ifn-γ [306]. |
| PubMedID- 20546603 | Vollmar et al have shown its immunomodulatory properties, in murine experimental autoimmune encephalomyelitis (eae), a t-cell-mediated central nervous system demyelinating disease model of multiple sclerosis. |
Page: 1